In ovarian cancer cases from Lynch syndrome families, deleterious variants in the MMR genes were mostly seen in END and CCC cases and were more prevalent in the MSH2 and MSH6 genes [56]. This evidence concerns the gene MRC1 and ovarian carcinoma.